Where does Evalve, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Evalve, Inc. ranks #3,966 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Evalve, Inc. hold?

Evalve, Inc. holds 91 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is Evalve, Inc.'s Innovation Score?

Evalve, Inc. has an Innovation Score of 40.1 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Evalve, Inc.'s patent grant rate increasing or decreasing?

Evalve, Inc.'s recent grant velocity is +215% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Evalve, Inc.'s patents?

Evalve, Inc.'s patents average 17.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Evalve, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Evalve, Inc.

Q: What technology areas does Evalve, Inc. focus on?

Evalve, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 79 patents, ranking #74 of 3,082 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 91 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Evalve ranks #3,966 of 49,997 tracked US assignees by granted-patent volume, with 91 patents across 4 technology areas.

#3,966
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.1/100): 17.4
avg claims per patent: +215%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3966 · US Corporation #3,966 · 91 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 91 grants
TOP-DECILE #3,966/49,997
PHOTO-FINISH Dana Italia S R L
CPC-NARROW A61F · 4 areas
INNOV-PAR 40.1/100
CLAIMS-RICH 17.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +215% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dana Italia S.R.L. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Evalve’s 40.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.6 pts (39%) Velocity 7.0 pts (17%) Breadth 7.1 pts (18%) Claim depth 10.4 pts (26%)

Qualcomm Incorporated · highest

85
Evalve · this assignee

40
Huf North America… · near

40
Indian Industries · near

40
RaySearch Laboratori… · near

40
Edwards Lifesciences… · near

40
3D Lighting… · lowest

7

What this shows Evalve's Innovation Score is 40.1/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Evalve?

Each dot is one of Evalve’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Evalve’s own 17.4 claims/patent is at or below the 17.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Evalve vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Evalve's grants concentrate

Evalve, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 86.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (20 grants) versus a trough of 1 in 2015. By volume, Evalve sits between Dana Italia S.R.L. and Iqvia Inc..

Evalve's three-year grant acceleration

From 2019–2021 to 2022–2024, Evalve, Inc. moved from 37 to 39 grants (1.05x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Dana Italia S R L

91
Dirtt Environment…

91
E G O Elektro-ger…

91
Esab AB

91
Galderma Holding

91
Hover

91
Idexx Laboratories

91
Iqvia

91
Evalve ◀

91

What this shows Evalve holds 91 patents at rank #3,966, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Evalve

By rank, the assignees closest to #3,966 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Evalve's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Evalve, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Evalve ranks #74 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

RaySearch Laboratories AB 40 Indian Industries, Inc. 40 Huf North America Automotive Parts Manufacturing Corp. 40 Edwards Lifesciences CardiAQ LLC 40

Similar claim depth

Nearest assignees by average claims per patent (17.4 here).

Bundesdruckerei GMBH 17.4 avg Trumpf Laser- UND Systemtechnik GMBH 17.4 avg Sphero, Inc. 17.4 avg The University of Birmingham 17.4 avg

Evalve's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Evalve, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	1.1%
2016	2	2.2%
2017	1	1.1%
2018	3	3.3%
2019	13	14.3%
2020	16	17.6%
2021	8	8.8%
2022	8	8.8%
2023	11	12.1%
2024	20	22.0%
2025partial year	8	8.8%

Which technologies does Evalve, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 79

A61B - DIAGNOSIS; SURGERY; Identification 74

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 23

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Evalve, Inc.'s patent record in context - here's where to go next.

Evalve, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 86.8% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #3,966 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Evalve, Inc. against Dana Italia S.R.L., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.